- Home
- AXSM vs MAIN Comparison
AXSM vs MAIN Comparison
Compare AXSM & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXSM | MAIN |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 4.8B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AXSM | MAIN |
|---|---|---|
| Price | $236.07 | $49.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 7 |
| Target Price | ★ $211.12 | $61.57 |
| AVG Volume (30 Days) | ★ 811.6K | 654.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 8.04% |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | N/A | N/A |
| Revenue This Year | $57.24 | $6.27 |
| Revenue Next Year | $55.88 | $5.14 |
| P/E Ratio | ★ N/A | $54.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $96.09 | $49.85 |
| 52 Week High | $235.92 | $67.77 |
Technical Indicators
Market Signals| Indicator | AXSM | MAIN |
|---|---|---|
| Relative Strength Index (RSI) | 73.42 | 34.97 |
| Support Level | $179.00 | N/A |
| Resistance Level | N/A | $58.82 |
| Average True Range (ATR) | 7.06 | 1.61 |
| MACD | -0.03 | -0.38 |
| Stochastic Oscillator | 95.81 | 6.10 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About MAIN Main Street Capital Corporation
Main Street Capital Corp is a principal investment firm focused on providing customized long-term debt and equity capital solutions to lower middle market ("LMM") companies and debt capital to private ("Private Loan") companies owned by or in the process of being acquired by a private equity fund. The group invests principally in secured debt investments, equity investments, warrants, and other securities of LMM companies, typically based in the U.S. The company operates as a single segment with a principal investment objective to maximize total return by generating current income from debt investments and current income and capital appreciation from equity and equity-related investments.